InsidersTradesSigma
Track the ProstaLund AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, ProstaLund AB has logged 5 public disclosures. The latest transaction was filed on 31 October 2025 (Purchase). Among the most active insiders: Mats Alyhr. All data is free.
5
Insider Decl.
n/a
Thresholds
€48,604
2 ops.
Buy Volume
€9,661
3 ops.
Sell Volume
15Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 October 2025
Declarations5 total
221,938 shares@ €0.018343.1% of flowAktieISIN SE0002372318FI:A003T259-1
221,938 shares@ €0.018343.1% of flowAktieISIN SE0002372318FI:A003T257-2
70,515 shares@ €0.018313.7% of flowAktieISIN SE0002372318FI:A003T258-1
2,500,000 shares@ €0.0178100.0% of flowAktieISIN SE0002372318FI:A003Q709-1
52,783 shares@ €0.0816100.0% of flowAktieISIN SE0002372318FI:A003Q500-1
5 of 5 declarations
About ProstaLund AB
ProstaLund AB is a company focused on developing treatments for prostate disorders. It is listed on the Stockholm Stock Exchange (XSTO).